Dilated cardiomyopathy resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 80: Line 80:
❑  Extremities:
❑  Extremities:
:❑&nbsp;&nbsp;Temperature of lower extremities</div>}}
:❑&nbsp;&nbsp;Temperature of lower extremities</div>}}
{{familytree | | | | | | | | E01 | |E01=<div style="text-align: left;"><b><u>Laboratory findings:</u></b><br>


❑&nbsp;&nbsp;Complete blood count


❑&nbsp;&nbsp;Chemistry
:❑&nbsp;&nbsp;Serum electrolytes (including calcium and magnesium)
:❑&nbsp;&nbsp;Blood urea nitrogen


:❑&nbsp;&nbsp;Serum creatinine
:❑&nbsp;&nbsp;Glucose
:❑&nbsp;&nbsp;Fasting lipid profile
:❑&nbsp;&nbsp;Liver function tests
:❑&nbsp;&nbsp;Thyroid-stimulating hormone
:❑&nbsp;&nbsp;Troponin, BNP or NT-proBNP
:❑&nbsp;&nbsp;Consider Screening for [[hemochromatosis]], [[HIV]], [[rheumatologic diseases]], [[amyloidosis]], or [[pheochromocytoma]]
:❑&nbsp;&nbsp;Urinalysis</div>}}




{{familytree | | | | | | | | E01 | |E01=A01}}
{{familytree | | | | | | | | F01 | |F01=A01}}
{{familytree | | | | | | | | F01 | |F01=A01}}
{{familytree | | | | | | | | |!| | | | | | |}}  
{{familytree | | | | | | | | |!| | | | | | |}}  

Revision as of 16:38, 5 March 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Steven Bellm, M.D. [2]

Dilated cardiomyopathy resident survival guide Microchapters
Overview
Causes
Diagnosis
Treatment
Do's
Dont's

Overview

Dilated cardiomyopathy (DCM) relates to a group of heterogeneous myocardial disorders and is characterized by dilatation and impaired contraction and systolic function of the left or both ventricles. Atrial and/or ventricular arrhythmias can occcur, and there is a risk for sudden death. [1] The weight of the heart is increased but the maximal thicknesses of the left ventricular free wall and septum are usually normal as a result of the abnormally dilated chambers.[2]

Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.[3]

  • Life-threatening causes:
  • Common causes:

Complete Diagnostic Approach

A complete diagnostic approach should be carried out after a focused initial rapid evaluation is conducted and following initiation of any urgent intervention.[4]


 
 
 
 
 
 
 
Symptoms of heart failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
History and symptpms:

❑  Hints for etiology (family history, and others)
❑  Duration and onset of illness
❑  Severity and triggers of dyspnea and fatigue, presence of chest pain, exercise capacity, physical activity, sexual activity (NYHA?)
❑  Weight loss/weight gain (cachexia/volume overload?)
❑  Palpitations/(pre)syncope/ICD shocks(adverse prognosis)
❑  Symptoms of transient ischemic attack or thromboembolism (anticoagulation necessary?)
❑  Presence of peripheral edema or ascites (volume overload?)
❑  Problems with breathing at night/ sleep
❑  Medical history:

❑  Prior hospitalizations for HF (adverse prognosis?)
❑  Discontinuation of medications (reasons?)
❑  Medications that may exacerbate HF
❑  Diet (restriction of sodium and fluid intake?)
 
 
 
 
 
 
 
 
Physical examination:

❑  Vital signs:

❑  Pulse (strength and regularity?)
❑  Blood pressure (supine and upright) to reflect adequacy of cardiac output
❑  Respiratory rate

❑  General appearance:

❑  BMI(weight loss/weight gain)
❑  Peripheral edema

❑  Heart:

❑  Extra heart sounds and murmurs (S³ associated with adverse prognosis, valvular heart disease?)
❑  Orthostatic changes in blood pressure and heart rate (volume status/vasodilation?)
❑  Jugular venous pressure at rest and following abdominal compression (to identify congestion)
❑  Size and location of point of maximal impulse (ventricular enlargement?)
❑  Right ventricular heave (right ventricular dysfunction and/or pulmonary hypertension?)

❑  Lungs:

❑  Rales
❑  Pleural effusion

❑  Abdomen:

❑  Hepatomegaly and/or ascites (volume overload)

❑  Extremities:

❑  Temperature of lower extremities
 
 
 
 
 
 
 
 
Laboratory findings:

❑  Complete blood count

❑  Chemistry

❑  Serum electrolytes (including calcium and magnesium)
❑  Blood urea nitrogen
❑  Serum creatinine
❑  Glucose
❑  Fasting lipid profile
❑  Liver function tests
❑  Thyroid-stimulating hormone
❑  Troponin, BNP or NT-proBNP
❑  Consider Screening for hemochromatosis, HIV, rheumatologic diseases, amyloidosis, or pheochromocytoma
❑  Urinalysis
 
 
 
 
 
 
 
 
A01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B01
 
 
 
 
 
 
 
B02
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C01
 
 
 
 
 
 
 
 
 
 
 

Treatment

shown

hidden

Do's

Dont's

References

  1. "Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies". Br Heart J. 44 (6): 672–3. 1980. PMC 482464. PMID 7459150.
  2. Tazelaar HD, Billingham ME (1986). "Leukocytic infiltrates in idiopathic dilated cardiomyopathy. A source of confusion with active myocarditis". Am J Surg Pathol. 10 (6): 405–12. PMID 3521345.
  3. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL; et al. (2000). "Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy". N Engl J Med. 342 (15): 1077–84. doi:10.1056/NEJM200004133421502. PMID 10760308.
  4. Yancy, C. W.; Jessup, M.; Bozkurt, B.; Butler, J.; Casey, D. E.; Drazner, M. H.; Fonarow, G. C.; Geraci, S. A.; Horwich, T.; Januzzi, J. L.; Johnson, M. R.; Kasper, E. K.; Levy, W. C.; Masoudi, F. A.; McBride, P. E.; McMurray, J. J. V.; Mitchell, J. E.; Peterson, P. N.; Riegel, B.; Sam, F.; Stevenson, L. W.; Tang, W. H. W.; Tsai, E. J.; Wilkoff, B. L. (2013). "2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Circulation. 128 (16): e240–e327. doi:10.1161/CIR.0b013e31829e8776. ISSN 0009-7322.